The MarketWatch News Department was not involved in the creation of this content. -- Peer-reviewed data published in Neurosurgery show that SOLOPASS(R) 2.0 delivers significantly higher accuracy than ...
98% of placements using SOLOPASS® 2.0 entered the ventricular system, versus only 10% of freehand placements. 86% of placements using SOLOPASS® 2.0 accurately reached the ipsilateral frontal horn ...